Established in January 2000 by the Public Health Research Institute (PHRI), the Center for Applied Genomics (CAG) explores and implements functional genomic and proteomic technologies.
The CAG collaborates with the scientists at PHRI as well as the scientists and physicians at the University of Medicine & Dentistry of New Jersey (UMDNJ), the New Jersey Institute of Technology (NJIT), Stevens Institute of Technology and universities, hospitals, government labs and businesses worldwide.
The CAG research facility is located in Newark, NJ and is directed by co-founder Dr. Patricia Soteropoulos.
A primary goal of the CAG is to provide microarray technology expertise and to create successful collaborative research partnerships to fully leverage this technology to solve biological and medical research problems.
The CAG also has the fundamental goal of advancing microarray technology, communicating these advances and rapidly applying them to medical and biological research.
From its inception, the CAG has acted as a hub for collaborative research projects. Over the past 6 years, the CAG has worked with more than 150 collaborators and service customers in institutions throughout the world.
The CAG has produced and distributed thousands of microarrays to researchers around the world and has developed methods and protocols for a diverse array of microarray applications. The CAG has a reputation for its high quality microarray printing and processing
The CAG has a core focus on technology development and is pursuing research in several directions including: next generation DNA microarrays, protein arrays, microarray printing technologies and novel array based analytical methods.
The Center also has extensive experience developing protein chip resources, assays and applications as well as bioinformatics solutions and data mining tools.
The CAG is a non-profit center that receives funding through research grants from public and private sources, research collaborations and from user and service fees.
